Sulfatase activities towards the regulation of cell metabolism and signaling in mammals.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 20165970)

Published in Cell Mol Life Sci on November 22, 2009

Authors

M Buono1, Maria Pia Cosma

Author Affiliations

1: Telethon Institute of Genetics and Medicine (TIGEM), CNR, via P. Castellino, 111, 80134, Naples, Italy.

Articles cited by this

(truncated to the top 100)

Intracellular functions of N-linked glycans. Science (2001) 8.39

Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem (2001) 7.87

Molecular diversity of heparan sulfate. J Clin Invest (2001) 5.40

The mannose-6-phosphate receptor for lysosomal enzymes is concentrated in cis Golgi cisternae. Cell (1984) 3.97

Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin. Cell (2001) 3.78

Quantitative proteomics analysis of the secretory pathway. Cell (2006) 3.63

A block of autophagy in lysosomal storage disorders. Hum Mol Genet (2007) 3.28

Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase. Science (2001) 3.22

How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum. Mol Biol Cell (1994) 3.11

Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme. Cell (2003) 2.93

QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J Cell Biol (2003) 2.88

Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J Biol Chem (2002) 2.86

Mannose 6-phosphate receptors and lysosomal enzyme targeting. J Biol Chem (1989) 2.77

Biosynthesis and turnover of the mannose 6-phosphate receptor in cultured Chinese hamster ovary cells. J Biol Chem (1983) 2.73

Binding of GGA2 to the lysosomal enzyme sorting motif of the mannose 6-phosphate receptor. Science (2001) 2.71

The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases. Cell (2003) 2.71

Identification and characterization of cells deficient in the mannose 6-phosphate receptor: evidence for an alternate pathway for lysosomal enzyme targeting. Proc Natl Acad Sci U S A (1983) 2.67

Dally cooperates with Drosophila Frizzled 2 to transduce Wingless signalling. Nature (1999) 2.53

Cooperation of GGAs and AP-1 in packaging MPRs at the trans-Golgi network. Science (2002) 2.28

Sulfatases: structure, mechanism, biological activity, inhibition, and synthetic utility. Angew Chem Int Ed Engl (2004) 2.18

Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J Biol Chem (2003) 2.06

ERp44, a novel endoplasmic reticulum folding assistant of the thioredoxin family. EMBO J (2002) 1.98

Thiol-mediated protein retention in the endoplasmic reticulum: the role of ERp44. EMBO J (2003) 1.96

A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy. Cell (1995) 1.95

Domain-specific modification of heparan sulfate by Qsulf1 modulates the binding of the bone morphogenetic protein antagonist Noggin. J Biol Chem (2003) 1.83

The lectin ERGIC-53 is a cargo transport receptor for glycoproteins. Nat Cell Biol (1999) 1.82

Mr 46,000 mannose 6-phosphate specific receptor: its role in targeting of lysosomal enzymes. EMBO J (1987) 1.81

Cerebroside 3-sulfate as a physiological substrate of arylsulfatase A. Biochim Biophys Acta (1968) 1.80

Genetic evidence that heparin-like glycosaminoglycans are involved in wingless signaling. Development (1997) 1.74

Autophagy in Niemann-Pick C disease is dependent upon Beclin-1 and responsive to lipid trafficking defects. Hum Mol Genet (2007) 1.73

QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis. Proc Natl Acad Sci U S A (2004) 1.71

Molecular basis for multiple sulfatase deficiency and mechanism for formylglycine generation of the human formylglycine-generating enzyme. Cell (2005) 1.71

Steroid sulfatase: molecular biology, regulation, and inhibition. Endocr Rev (2004) 1.69

HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo. J Biol Chem (2005) 1.66

Substrate specificity and domain functions of extracellular heparan sulfate 6-O-endosulfatases, QSulf1 and QSulf2. J Biol Chem (2005) 1.64

Spatially restricted expression of pipe in the Drosophila egg chamber defines embryonic dorsal-ventral polarity. Cell (1998) 1.63

Sulfatases and human disease. Annu Rev Genomics Hum Genet (2005) 1.63

Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells. J Clin Invest (2004) 1.59

Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling. J Biol Chem (2008) 1.57

The heparanome--the enigma of encoding and decoding heparan sulfate sulfation. J Biotechnol (2007) 1.57

Structure of a human lysosomal sulfatase. Structure (1997) 1.57

The molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouse. J Biol Chem (2001) 1.55

Crystal structure of human arylsulfatase A: the aldehyde function and the metal ion at the active site suggest a novel mechanism for sulfate ester hydrolysis. Biochemistry (1998) 1.48

Heparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional co-operativity. Biochem J (2006) 1.48

Proteoglycan desulfation determines the efficiency of chondrocyte autophagy and the extent of FGF signaling during endochondral ossification. Genes Dev (2008) 1.46

Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survival. PLoS One (2007) 1.44

Sequential steps and checkpoints in the early exocytic compartment during secretory IgM biogenesis. EMBO J (2007) 1.43

Sulfation pattern in glycosaminoglycan: does it have a code? Glycoconj J (2004) 1.43

Multistep, sequential control of the trafficking and function of the multiple sulfatase deficiency gene product, SUMF1 by PDI, ERGIC-53 and ERp44. Hum Mol Genet (2008) 1.43

Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc Natl Acad Sci U S A (2004) 1.42

Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship. Hum Mol Genet (2005) 1.40

pH-induced conversion of the transport lectin ERGIC-53 triggers glycoprotein release. J Biol Chem (2004) 1.38

Deficiency of chondroitin sulfate N-acetylgalactosamine 4-sulfate sulfatase in Maroteaux-Lamy syndrome. Biochem Biophys Res Commun (1974) 1.36

Molecular characterization of the human Calpha-formylglycine-generating enzyme. J Biol Chem (2005) 1.35

Human N-acetylgalactosamine-4-sulphate sulphatase. Purification, monoclonal antibody production and native and subunit Mr values. Biochem J (1987) 1.34

Defects in glucuronate biosynthesis disrupt Wingless signaling in Drosophila. Development (1997) 1.33

Targeted disruption of the M(r) 46,000 mannose 6-phosphate receptor gene in mice results in misrouting of lysosomal proteins. EMBO J (1993) 1.31

Sequence determinants directing conversion of cysteine to formylglycine in eukaryotic sulfatases. EMBO J (1999) 1.31

Redundant function of the heparan sulfate 6-O-endosulfatases Sulf1 and Sulf2 during skeletal development. Dev Dyn (2008) 1.30

Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma. Cancer Res (2003) 1.25

Systemic inflammation and neurodegeneration in a mouse model of multiple sulfatase deficiency. Proc Natl Acad Sci U S A (2007) 1.25

Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery. Hum Mol Genet (2006) 1.21

Biochemical, pathological, and skeletal improvement of mucopolysaccharidosis VI after gene transfer to liver but not to muscle. Mol Ther (2007) 1.21

The human SUMF1 gene, required for posttranslational sulfatase modification, defines a new gene family which is conserved from pro- to eukaryotes. Gene (2003) 1.20

Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes. Hum Mol Genet (2007) 1.20

Morquio's syndrome: deficiency of a chondroitin sulfate N-acetylhexosamine sulfate sulfatase. Biochem Biophys Res Commun (1974) 1.19

The distribution of 215-kilodalton mannose 6-phosphate receptors within cis (heavy) and trans (light) Golgi subfractions varies in different cell types. Proc Natl Acad Sci U S A (1987) 1.18

Maroteaux-Lamy disease (mucopolysaccharidosis VI), subtype A: deficiency of a N-acetylgalactosamine-4-sulfatase. Biochem Biophys Res Commun (1974) 1.17

Human sulfatases: a structural perspective to catalysis. Cell Mol Life Sci (2007) 1.16

Cerebroside-sulphatase and arylsulphatase A deficiency in metachromatic leukodystrophy (ML). J Neurochem (1969) 1.16

Sulfotransferases and sulfated oligosaccharides. Med Res Rev (2002) 1.14

Structure of human estrone sulfatase suggests functional roles of membrane association. J Biol Chem (2003) 1.10

Transporters of nucleotide sugars, nucleotide sulfate and ATP in the Golgi apparatus. Trends Biochem Sci (1997) 1.08

Cloning and expression of human steroid-sulfatase. Membrane topology, glycosylation, and subcellular distribution in BHK-21 cells. J Biol Chem (1989) 1.07

Role of N-linked polymannose oligosaccharides in targeting glycoproteins for endoplasmic reticulum-associated degradation. Cell Mol Life Sci (2004) 1.06

Sulfs are regulators of growth factor signaling for satellite cell differentiation and muscle regeneration. Dev Biol (2007) 1.05

Expression, purification and characterization of recombinant human N-acetylgalactosamine-6-sulphatase. Biochem J (1995) 1.03

SUMF1 enhances sulfatase activities in vivo in five sulfatase deficiencies. Biochem J (2007) 1.02

Intracellular sorting of aspartylglucosaminidase: the role of N-linked oligosaccharides and evidence of Man-6-P-independent lysosomal targeting. DNA Cell Biol (1995) 1.00

Amino acid residues forming the active site of arylsulfatase A. Role in catalytic activity and substrate binding. J Biol Chem (1999) 0.99

Importance of estrogen sulfates in breast cancer. J Steroid Biochem (1989) 0.99

X-linked ichthyosis, due to steroid sulphatase deficiency, associated with Kallmann syndrome (hypogonadotropic hypogonadism and anosmia): linkage relationships with Xg and cloned DNA sequences from the distal short arm of the X chromosome. Hum Genet (1986) 0.99

Molecular genetics of the ichthyoses. Am J Med Genet C Semin Med Genet (2004) 0.98

Expression, purification and characterization of recombinant caprine N-acetylglucosamine-6-sulphatase. Biochem J (1997) 0.97

Roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the signal transduction of basic fibroblast growth factor in endothelial cells during angiogenesis. Jpn J Cancer Res (1999) 0.97

Sulfatase modifying factor 1 trafficking through the cells: from endoplasmic reticulum to the endoplasmic reticulum. EMBO J (2007) 0.97

ERp44 mediates a thiol-independent retention of formylglycine-generating enzyme in the endoplasmic reticulum. J Biol Chem (2008) 0.96

Sulfatases, trapping of the sulfated enzyme intermediate by substituting the active site formylglycine. J Biol Chem (1998) 0.94

IDS crossing of the blood-brain barrier corrects CNS defects in MPSII mice. Am J Hum Genet (2009) 0.94

L-ascorbic acid 2-sulphate. A substrate for mammalian arylsulphatases. Biochim Biophys Acta (1975) 0.92

Antibody to the phosphomannosyl receptor inhibits recycling of receptor in fibroblasts. J Cell Biochem (1987) 0.89

Role of sperm surface arylsulfatase A in mouse sperm-zona pellucida binding. Biol Reprod (2002) 0.89

Human liver N-acetylgalactosamine 6-sulphatase. Purification and characterization. Biochem J (1991) 0.88

A model of corrective gene transfer in X-linked ichthyosis. Hum Mol Genet (1997) 0.88

Diseases of abnormal protein glycosylation: an emerging area. J Clin Invest (1998) 0.84

IDS transfer from overexpressing cells to IDS-deficient cells. Exp Cell Res (1997) 0.81

Sulphamidase. Int J Biochem Cell Biol (1999) 0.80

The activity of arylsulfatase A and B on tyrosine O-sulfates. Biochim Biophys Acta (1979) 0.80

Activator-dependent hydrolysis of myelin cerebroside sulfate by arylsulfatase A. Dev Neurosci (1991) 0.75

Recent developments in the biochemistry of globoid and metachromatic leucodystrophies. Biomedicine (1977) 0.75

Articles by these authors

A yeast synthetic network for in vivo assessment of reverse-engineering and modeling approaches. Cell (2009) 4.11

Periodic activation of Wnt/beta-catenin signaling enhances somatic cell reprogramming mediated by cell fusion. Cell Stem Cell (2008) 1.78

Multistep, sequential control of the trafficking and function of the multiple sulfatase deficiency gene product, SUMF1 by PDI, ERGIC-53 and ERp44. Hum Mol Genet (2008) 1.43

Systemic inflammation and neurodegeneration in a mouse model of multiple sulfatase deficiency. Proc Natl Acad Sci U S A (2007) 1.25

Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery. Hum Mol Genet (2006) 1.21

Wnt/β-catenin signaling triggers neuron reprogramming and regeneration in the mouse retina. Cell Rep (2013) 1.10

SUMF1 enhances sulfatase activities in vivo in five sulfatase deficiencies. Biochem J (2007) 1.02

Correction of CNS defects in the MPSII mouse model via systemic enzyme replacement therapy. Hum Mol Genet (2010) 1.02

Cell-fusion-mediated somatic-cell reprogramming: a mechanism for tissue regeneration. J Cell Physiol (2010) 0.98

Sulfatase modifying factor 1 trafficking through the cells: from endoplasmic reticulum to the endoplasmic reticulum. EMBO J (2007) 0.97

Sulphatase activities are regulated by the interaction of sulphatase-modifying factor 1 with SUMF2. EMBO Rep (2005) 0.95

T-cell factor 3 (Tcf3) deletion increases somatic cell reprogramming by inducing epigenome modifications. Proc Natl Acad Sci U S A (2011) 0.94

IDS crossing of the blood-brain barrier corrects CNS defects in MPSII mice. Am J Hum Genet (2009) 0.94

Mutational analysis of the HGSNAT gene in Italian patients with mucopolysaccharidosis IIIC (Sanfilippo C syndrome). Mutation in brief #959. Online. Hum Mutat (2007) 0.91

The Wnt/β-catenin signaling pathway tips the balance between apoptosis and reprograming of cell fusion hybrids. Stem Cells (2010) 0.87

Multiple sulfatase deficiency in a Turkish family resulting from a novel mutation. Brain Dev (2008) 0.84

How to turn a genetic circuit into a synthetic tunable oscillator, or a bistable switch. PLoS One (2009) 0.84

Development and maturation of invariant NKT cells in the presence of lysosomal engulfment. Eur J Immunol (2009) 0.83

Sulfatase modifying factor 1-mediated fibroblast growth factor signaling primes hematopoietic multilineage development. J Exp Med (2010) 0.81

Cell-fusion-mediated reprogramming: pluripotency or transdifferentiation? Implications for regenerative medicine. Adv Exp Med Biol (2011) 0.81

Somatic cell reprogramming control: signaling pathway modulation versus transcription factor activities. Cell Cycle (2009) 0.81

Reprogramming Müller glia via in vivo cell fusion regenerates murine photoreceptors. J Clin Invest (2016) 0.79

Regulation of self-renewal and reprogramming by TCF factors. Cell Cycle (2012) 0.78

Sulfatase modifying factor 1 trafficking through the cells: from endoplasmic reticulum to the endoplasmic reticulum. EMBO J (2016) 0.75

Sulfatase activities are regulated by the interaction of the sulfatase-modifying factor 1 with SUMF2. EMBO Rep (2016) 0.75

Ordered Recruitment of Transcription and Chromatin Remodeling Factors to a Cell Cycle- and Developmentally Regulated Promoter. Cell (2016) 0.75

Resetting epigenetic signatures to induce somatic cell reprogramming. Cell Mol Life Sci (2012) 0.75

Cdk1 Triggers Association of RNA Polymerase to Cell Cycle Promoters Only after Recruitment of the Mediator by SBF. Mol Cell (2016) 0.75